Start Early and See Inflammatory; Late, Nothing Save RAVE: How to Appreciate Radiation Proctitis as a Continuum

Area of Science:

• Oncology
• Gastroenterology
• Radiation Oncology

Background:

• Chronic radiation proctitis (CRP) nomenclature is debated, with a proposal to change it to "radiation-associated vascular ectasia" due to perceived lack of inflammation.
• This study investigates the role of inflammation in the pathogenesis of CRP, presenting data to support its critical involvement.

Purpose of the Study:

• To provide evidence supporting inflammation as a key initiating factor in the development of chronic radiation proctitis (CRP).
• To evaluate the expression of specific proinflammatory factors and their correlation with pathological changes in CRP.

Main Methods:

• Literature review on inflammation in CRP pathogenesis.
• Analysis of immunohistochemistry from rectal biopsies in a prospective pilot study.
• Assessment of amifostine treatment, p38 MAP kinase, VEGF, and CEACAM1 expression, alongside fibrosis and vascular scores.

Main Results:

• Vascular endothelial growth factor (VEGF) and CEACAM1 expression were elevated pre-radiotherapy and decreased over time.
• p38 MAP kinase expression typically preceded radiation exposure.
• Fibrosis scores increased at 9 and 18 months post-radiotherapy, while vascular scores decreased at 18 months.

Conclusions:

• The proposed shift in nomenclature for chronic radiation proctitis (CRP) to "radiation-associated vascular ectasia" requires further supporting data.
• CRP may represent a continuum of disease with inflammation-predominant, vasculopathy-predominant, or mixed forms.